| 2026 |
Dorward, E. L., Ortiz, M., Weekley, C. M., Myo Min, K. K., Duijf, P. H. G., Barreto, S. G., . . . Bonder, C. S. (2026). Unpacking the Tumor Protein D52-like Family: Roles in Intracellular Trafficking and Cancer Progression. Cells, 15(3), 252-1-252-36.
DOI |
| 2025 |
Mansoori, B., Najafi, S., Mohammadi, A., AsadollahSeraj, H., Savadi, P., Mansoori, B., . . . Baradaran, B. (2025). Corrigendum to: “The synergy between miR-486–5p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells”(Biomedicine & Pharmacotherapy, (2021), 141, C, (111925), (S0753332221007071), 10.1016/j.biopha.2021.111925). Biomedicine and Pharmacotherapy, 192, 118474.
DOI |
| 2025 |
Jakobsen, M. K., Traynor, S., Nielsen, A. Y., Dahl, C., Staehr, M., Jakobsen, S. T., . . . Gjerstorff, M. F. (2025). Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition. Journal Of Experimental & Clinical Cancer Research, 44(1, article no. 21), 1-15.
DOI Scopus12 WoS12 Europe PMC6 |
| 2025 |
Perera, G. S., Huang, X., Bagherjeri, F. A., Joglekar, C. M., Leo, P., Duijf, P., . . . Punyadeera, C. (2025). Rapid and selective detection of TP53 mutations in cancer using a novel conductometric biosensor. Biosensors and Bioelectronics, 276, 1-8.
DOI Scopus3 WoS3 Europe PMC1 |
| 2025 |
Thangavelu, P. U., Lin, C. Y., Forouz, F., Tanaka, K., Dray, E., & Duijf, P. H. G. (2025). The RB protein: more than a sentry of cell cycle entry. Trends in Molecular Medicine, online(12), 1-16.
DOI Scopus5 WoS5 |
| 2025 |
Zare, E., Yaghoubi, S. M., Khoshnazar, M., Jafari Dargahlou, S., Machhar, J. S., Zheng, Z., . . . Mansoori, B. (2025). MicroRNAs in Cancer immunology: master regulators of the Tumor microenvironment and immune evasion, with therapeutic potential. Cancers, 17(13, article no. 2172), 1-38.
DOI Scopus19 WoS20 |
| 2025 |
Rose, M., Burgess, J. T., Cheong, C. M., Richard, I., Suraweera, A., Adams, M. N., . . . Bolderson, E. (2025). The inner nuclear membrane protein, Banf1, has an essential role in triple negative breast cancer cell proliferation and survival. Scientific Reports, 15(1), 25492.
DOI Scopus1 WoS1 |
| 2024 |
Huang, X., Leo, P., Jones, L., Duijf, P. H. G., Hartel, G., Kenny, L., . . . Punyadeera, C. (2024). A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma - a systematic review. Mutation Research - Reviews in Mutation Research, 793(108477), 1-12.
DOI Scopus11 WoS10 Europe PMC8 |
| 2024 |
Avalos, B. D. L. P., Paquet, N., Tropée, R., Coulombe, Y., Palacios, H., Leung, J. W., . . . Dray, E. (2024). The protein phosphatase EYA4 promotes homologous recombination (HR) through dephosphorylation of tyrosine 315 on RAD51. Nucleic Acids Research, 52(3), 1173-1187.
DOI Scopus7 WoS7 Europe PMC9 |
| 2024 |
Joshi, V., Stacey, A., Feng, Y., Kalita de Croft, P., Duijf, P. H. G., Simpson, P. T., . . . McCart Reed, A. E. (2024). NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis. Journal of Pathology: Clinical Research, 10(2, article no. e12364), 1-16.
DOI Scopus6 WoS7 Europe PMC1 |
| 2024 |
Balakittnen, J., Ekanayake Weeramange, C., Wallace, D. F., Duijf, P. H. G., Cristino, A. S., Hartel, G., . . . Punyadeera, C. (2024). A novel saliva-based miRNA profile to diagnose and predict oral cancer. International Journal of Oral Science, 16(14), 1-13.
DOI Scopus46 WoS45 Europe PMC33 |
| 2024 |
Bhatia, S., Khanna, K. K., & Duijf, P. H. G. (2024). Targeting chromosomal instability and aneuploidy in cancer. Trends in Pharmacological Sciences, 45(3), 210-224.
DOI Scopus24 WoS24 Europe PMC19 |
| 2024 |
Shahrouzi, P., Forouz, F., Mathelier, A., Kristensen, V. N., & Duijf, P. H. G. (2024). Copy number alterations: a catastrophic orchestration of the breast cancer genome. Trends in Molecular Medicine, 30(8), 750-764.
DOI Scopus20 WoS21 Europe PMC18 |
| 2024 |
Shahrouzi, P., Azimzade, Y., Brankiewicz Kopcinska, W., Bhatia, S., Kunke, D., Richard, D., . . . Duijf, P. H. G. (2024). Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug response. Breast Cancer Research, 26(1), 1-19.
DOI Scopus2 WoS2 Europe PMC3 |
| 2024 |
Joshi, V., Beecher, K., Lim, M., Stacey, A., Feng, Y., Jat, P. S., . . . McCart Reed, A. E. (2024). B7-H3 expression in breast cancer and brain metastasis. International Journal of Molecular Sciences, 25(7), 1-17.
DOI Scopus14 WoS16 Europe PMC12 |
| 2023 |
Rashidieh, B., Bain, A. L., Tria, S. M., Sharma, S., Stewart, C. A., Simmons, J. L., . . . Khanna, K. K. (2023). Alpha-B-Crystallin overexpression is sufficient to promote tumorigenesis and metastasis in mice. Experimental Hematology & Oncology, 12(1, article no. 4), 1-19.
DOI Scopus5 WoS5 Europe PMC6 |
| 2023 |
Adams, M. N., Croft, L. V., Urquhart, A., Saleem, M. A. M., Rockstroh, A., Duijf, P. H. G., . . . Richard, D. J. (2023). hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen-induced transcriptional response in prostate cancer. Prostate, 83(7), 628-640.
DOI Scopus7 Europe PMC8 |
| 2023 |
Balakittnen, J., Weeramange, C. E., Wallace, D. F., Duijf, P. H. G., Cristino, A. S., Kenny, L., . . . Punyadeera, C. (2023). Noncoding RNAs in oral cancer. Wiley Interdisciplinary Reviews: RNA, 14(3, article no. e1754), 1-45.
DOI Scopus37 Europe PMC30 |
| 2023 |
Bhatia, S., Gunter, J. H., Burgess, J. T., Adams, M. N., O'Byrne, K., Thompson, E. W., & Duijf, P. H. G. (2023). Stochastic epithelial-mesenchymal transitions diversify non-cancerous lung cell behaviours. Translational Oncology, 37(101760), 1-18.
DOI Scopus2 WoS2 |
| 2023 |
Avalos, B. D. L. P., Tropee, R., Duijf, P. H. G., & Dray, E. (2023). EYA4 promotes breast cancer progression and metastasis through its role in replication stress avoidance. Molecular Cancer, 22(158), 1-18.
DOI Scopus11 WoS12 Europe PMC12 |
| 2023 |
Huang, X., Duijf, P. H. G., Sriram, S., Perera, G., Vasani, S., Kenny, L., . . . Punyadeera, C. (2023). Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma. Journal of Biomedical Science, 30(1), 65.
DOI Scopus31 Europe PMC24 |
| 2023 |
Asl, E. R., Rostamzadeh, D., Duijf, P. H. G., Mafi, S., Mansoori, B., Barati, S., . . . Mansoori, B. (2023). Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe. Life Sciences, 315, 121361.
DOI Scopus31 Europe PMC20 |
| 2023 |
Mansoori, B., Kiani, S., Mezajin, A. A., Zandi, P., Banaie, H., Rostamzadeh, D., . . . Baradaran, B. (2023). MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2. Clinical Breast Cancer, 23(7), e480-e490.e3.
DOI Scopus9 Europe PMC4 |
| 2022 |
Derakhshani, A., Javadrashid, D., Hemmat, N., Dufour, A., Solimando, A. G., Abdoli Shadbad, M., . . . Baradaran, B. (2022). Identification of common and distinct pathways in inflammatory bowel disease and colorectal cancer: a hypothesis based on weighted gene co-expression network analysis. Frontiers in Genetics, 13(848646), 1-12.
DOI Scopus14 |
| 2021 |
Mansoori, B., Najafi, S., Mohammadi, A., AsadollahSeraj, H., Savadi, P., Mansoori, B., . . . Baradaran, B. (2021). The synergy between miR-486-5p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells. Biomedicine and Pharmacotherapy, 141(111925), 111925.
DOI Scopus10 Europe PMC9 |
| 2021 |
Sahin, K. B., Shah, E. T., Ferguson, G. P., Molloy, C., Duijf, P. H. G., & Adams, M. N. (2021). Elevating CDCA3 levels enhances tyrosine kinase inhibitor sensitivity in TKI-resistant EGFR mutant non-small-cell lung cancer. Cancers, 13(18, article no. 4651), 4651.
DOI Scopus11 |
| 2021 |
Kildey, K., Gandhi, N. S., Sahin, K. B., Shah, E. T., Boittier, E., Duijf, P. H. G., . . . Adams, M. N. (2021). Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy. Communications Biology, 4(1, article no. 638), 638.
DOI Scopus27 Europe PMC23 |
| 2021 |
Rashidieh, B., Molakarimi, M., Mohseni, A., Tria, S. M., Truong, H., Srihari, S., . . . Khanna, K. K. (2021). Targeting brf2 in cancer using repurposed drugs. Cancers, 13(15, article no. 3778), 3778.
DOI Scopus14 |
| 2021 |
Mansoori, B., Silvestris, N., Mohammadi, A., Khaze, V., Baghbani, E., Mokhtarzadeh, A., . . . Baradaran, B. (2021). Mir‐34a and mir‐200c have an additive tumor‐suppressive effect on breast cancer cells and patient prognosis. Genes, 12(2, article no. 267), 1-17.
DOI Scopus50 Europe PMC37 |
| 2021 |
Jakobsen, M. K., Traynor, S., Stæhr, M., Duijf, P. G., Nielsen, A. Y., Terp, M. G., . . . Gjerstorff, M. F. (2021). The cancer/testis antigen gene VCX2 is rarely expressed in malignancies but can be epigenetically activated using DNA methyltransferase and histone deacetylase inhibitors. Frontiers in Oncology, 10(584024), 1-12.
DOI Scopus20 |
| 2021 |
Fernando, M., Duijf, P. H. G., Proctor, M., Stevenson, A. J., Ehmann, A., Vora, S., . . . Gabrielli, B. (2021). Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours. Oncogenesis, 10(5, article no. 41).
DOI Scopus22 |
| 2021 |
Mansoori, B., Duijf, P. H. G., Mohammadi, A., Safarzadeh, E., Ditzel, H. J., Gjerstorff, M. F., . . . Baradaran, B. (2021). MiR-142-3p targets HMGA2 and suppresses breast cancer malignancy. Life Sciences, 276(119431), 119431.
DOI Scopus43 Europe PMC35 |
| 2021 |
Wiegmans, A. P., Ward, A., Ivanova, E., Duijf, P. H. G., Adams, M. N., Najib, I. M., . . . Richard, D. J. (2021). Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer. NAR Cancer, 3(2, article no. zcab022), 1-11.
DOI Scopus14 |
| 2021 |
Safarzadeh, E., Mohammadi, A., Mansoori, B., Duijf, P. H. G., Hashemzadeh, S., Khaze, V., . . . Baradaran, B. (2021). STAT3 silencing and TLR7/8 pathway activation repolarize and suppress myeloid-derived suppressor cells from breast cancer patients. Frontiers in Immunology, 11(613215), 1-14.
DOI Scopus25 Europe PMC21 |
| 2021 |
Mohammadi, A., Mansoori, B., Duijf, P. H. G., Safarzadeh, E., Tebbi, L., Najafi, S., . . . Baradaran, B. (2021). Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migration. Journal of Cellular Physiology, 236(1), 273-283.
DOI Scopus18 Europe PMC15 |
| 2021 |
Tropée, R., de la Peña Avalos, B., Gough, M., Snell, C., Duijf, P. H. G., & Dray, E. (2021). The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer. Breast Cancer Research and Treatment, 185(3), 601-614.
DOI Scopus22 Europe PMC22 |
| 2021 |
Suraweera, A., Duijf, P. H. G., Jekimovs, C., Schrobback, K., Liu, C., Adams, M. N., . . . Richard, D. J. (2021). Commd1, from the repair of dna double strand breaks, to a novel anti-cancer therapeutic target. Cancers, 13(4, article no. 830), 1-20.
DOI Scopus6 |
| 2021 |
Mansoori, B., Mohammadi, A., Ditzel, H. J., Duijf, P. H. G., Khaze, V., Gjerstorff, M. F., & Baradaran, B. (2021). Hmga2 as a critical regulator in cancer development. Genes, 12(2), 1-23.
DOI Scopus161 Europe PMC151 |
| 2021 |
baghbani, E., Noorolyai, S., Duijf, P. H. G., Silvestris, N., Kolahian, S., Hashemzadeh, S., . . . Baradaran, B. (2021). The impact of microRNAs on myeloid-derived suppressor cells in cancer. Human Immunology, 82(9), 668-678.
DOI Scopus5 Europe PMC5 |
| 2021 |
Janysek, D. C., Kim, J., Duijf, P. H. G., & Dray, E. (2021). Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers. Translational Oncology, 14(3), 101012.
DOI Scopus45 |
| 2021 |
Suraweera, A., Duff, A., Adams, M. N., Jekimovs, C., Duijf, P. H. G., Liu, C., . . . Richard, D. J. (2021). Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer (British Journal of Cancer, (2020), 123, 4, (591-603), 10.1038/s41416-020-0899-2). British Journal of Cancer, 124(9), 1612.
DOI |
| 2021 |
Wiegmans, A. P., Ward, A., Ivanova, E., Duijf, P. H. G., Adams, M. N., Najib, I. M., . . . Richard, D. J. (2021). Correction to ‘Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer’. Nar Cancer, 3(3).
DOI |
| 2020 |
Shirjang, S., Mansoori, B., Asghari, S., Duijf, P. H., Mohammadi, A., Gjerstorff, M., & Baradaran, B. (2020). Corrigendum to “MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis” (Free Radical Biology and Medicine (2019) 139 (1–15), (S0891584919301844), (10.1016/j.freeradbiomed.2019.05.017)). Free Radical Biology and Medicine, 146, 402.
DOI Scopus4 |
| 2020 |
Naghizadeh, S., Mohammadi, A., Duijf, P. H. G., Baradaran, B., Safarzadeh, E., Cho, W. C. S., & Mansoori, B. (2020). The role of miR-34 in cancer drug resistance. Journal of Cellular Physiology, 235(10), 6424-6440.
DOI Scopus31 Europe PMC25 |
| 2020 |
Mansoori, B., Mohammadi, A., Naghizadeh, S., Gjerstorff, M., Shanehbandi, D., Shirjang, S., . . . Baradaran, B. (2020). miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer. Journal of Cellular Physiology, 235(2), 920-931.
DOI Scopus57 Europe PMC47 |
| 2020 |
Mansoori, B., Duijf, P. H. G., Mohammadi, A., Najafi, S., Roshani, E., Shanehbandi, D., . . . Baradaran, B. (2020). Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness. Expert Opinion on Therapeutic Targets, 24(3), 255-265.
DOI Scopus53 Europe PMC46 |
| 2020 |
Abdel Fatah, T. M. A., Ball, G. R., Thangavelu, P. U., Reid, L. E., McCart Reed, A. E., Saunus, J. M., . . . Chan, S. Y. T. (2020). Association of sperm-associated antigen 5 and treatment response in patients with estrogen receptor-positive breast cancer. JAMA network open, 3(7, article no. e209486), 1-14.
DOI Scopus2 Europe PMC2 |
| 2020 |
Suraweera, A., Duff, A., Adams, M. N., Jekimovs, C., Duijf, P. H. G., Liu, C., . . . Richard, D. J. (2020). Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer. British Journal of Cancer, 123(4), 591-603.
DOI Scopus17 Europe PMC16 |
| 2020 |
Burgess, J. T., Bolderson, E., Adams, M. N., Duijf, P. H. G., Zhang, S. D., Gray, S. G., . . . O'Byrne, K. J. (2020). SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer. Scientific Reports, 10(1, article no. 18605), 1-10.
DOI Scopus23 Europe PMC23 |
| 2020 |
Khanna, K. K., & Duijf, P. H. G. (2020). Complexities of pharmacogenomic interactions in cancer. Molecular & Cellular Oncology, 7(3, article no. e1735910), 1735910.
DOI Scopus5 |
| 2020 |
Shirjang, S., Mansoori, B., Mohammadi, A., Shajari, N., Duijf, P. H. G., Najafi, S., . . . Baradaran, B. (2020). Mir-330 regulates colorectal cancer oncogenesis by targeting BACH1. Advanced Pharmaceutical Bulletin, 10(3), 444-451.
DOI Scopus26 |
| 2020 |
Shukla, A., Nguyen, T. H. M., Moka, S. B., Ellis, J. J., Grady, J. P., Oey, H., . . . Duijf, P. H. G. (2020). Chromosome arm aneuploidies shape tumour evolution and drug response. Nature Communications, 11(1, article no. 449), 1-14.
DOI Scopus88 Europe PMC102 |
| 2020 |
Duijf, P. H. G. (2020). Low baseline pulmonary levels of cytotoxic lymphocytes as a predisposing risk factor for severe COVID-19. mSystems, 5(5, article no. e00741-20), 1-13.
DOI Scopus9 |
| 2020 |
Fachal, L., Aschard, H., Beesley, J., Barnes, D. R., Duijf, P., & Dunning, A. M. (2020). Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics, 52(1), 56-73.
DOI Scopus132 WoS127 Europe PMC154 |
| 2020 |
Sinha, D., Nag, P., Nanayakkara, D., Duijf, P. H. G., Burgess, A., Raninga, P., . . . Khanna, K. K. (2020). Cep55 overexpression promotes genomic instability and tumorigenesis in mice.. Communications Biology, 3(1), 593.
DOI Scopus32 WoS31 Europe PMC32 |
| 2019 |
Li, A., Geyer, F. C., Blecua, P., Lee, J. Y., Selenica, P., Brown, D. N., . . . Stone, J. (2019). Homologous recombination DNA repair defects in PALB2-associated breast cancers. npj Breast Cancer, 5(1), 23-1-23-14.
DOI Scopus46 WoS47 Europe PMC44 |
| 2019 |
Brown, P., Tan, A. -C., El-Esawi, M. A., Liehr, T., Blanck, O., Gladue, D. P., . . . Zhou, Y. (2019). Large expert-curated database for benchmarking document similarity detection in biomedical literature search. Database: the journal of biological databases and curation, 2019(baz085), baz085-1-baz085-66.
DOI Scopus31 WoS38 Europe PMC15 |
| 2019 |
Li, A., Geyer, F., Blecua, P., Lee, J., Selenica, P., Brown, D., . . . Stone, J. (2019). Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9). npj Breast Cancer, 5(1).
DOI |
| 2019 |
Al Emran, A., Marzese, D. M., Menon, D. R., Hammerlindl, H., Ahmed, F., Richtig, E., . . . Schaider, H. (2019). Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer. Epigenomics, 11(7), 723-737.
DOI Scopus20 Europe PMC14 |
| 2019 |
Shomali, N., Shirafkan, N., Duijf, P. H. G., Ghasabi, M., Babaloo, Z., Yousefi, M., . . . Baradaran, B. (2019). Downregulation of miR-146a promotes cell migration in Helicobacter pylori-negative gastric cancer. Journal of Cellular Biochemistry, 120(6), 9495-9505.
DOI Scopus28 Europe PMC17 |
| 2019 |
Mansoori, B., Mohammadi, A., Asadzadeh, Z., Shirjang, S., Minouei, M., Abedi Gaballu, F., . . . Baradaran, B. (2019). HMGA2 and Bach-1 cooperate to promote breast cancer cell malignancy. Journal of Cellular Physiology, 234(10), 17714-17726.
DOI Scopus41 Europe PMC35 |
| 2019 |
Mansoori, B., Mohammadi, A., Gjerstorff, M. F., Shirjang, S., Asadzadeh, Z., Khaze, V., . . . Baradaran, B. (2019). miR-142-3p is a tumor suppressor that inhibits estrogen receptor expression in ER-positive breast cancer. Journal of Cellular Physiology, 234(9), 16043-16053.
DOI Scopus50 Europe PMC34 |
| 2019 |
Bhatia, S., Monkman, J., Blick, T., Duijf, P. H. G., Nagaraj, S. H., & Thompson, E. W. (2019). Multi-omics characterization of the spontaneous mesenchymal-epithelial transition in the PMC42 breast cancer cell lines. Journal of Clinical Medicine, 8(8, article no. 1253), 1-31.
DOI Scopus21 |
| 2019 |
Safarzadeh, E., Shahryar, H., Duijf, P. H. G., Mansoori, B., Khaze, V., Mohammadi, A., . . . Baradaran, B. (2019). Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer. Journal of Cellular Physiology, 234(4), 3515-3525.
DOI Scopus72 Europe PMC67 |
| 2019 |
Brückmann, N. H., Bennedsen, S. N., Duijf, P. H. G., Terp, M. G., Thomassen, M., Larsen, M., . . . Gjerstorff, M. F. (2019). A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescence. Cell Death and Disease, 10(11, article no. 841), 1-12.
DOI Scopus4 Europe PMC4 |
| 2019 |
Mansoori, B., Mohammadi, A., Ghasabi, M., Shirjang, S., Dehghan, R., Montazeri, V., . . . Baradaran, B. (2019). miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression. Journal of Cellular Physiology, 234(6), 9816-9825.
DOI Scopus115 Europe PMC94 |
| 2019 |
Sinha, D., Duijf, P. H. G., & Khanna, K. K. (2019). Mitotic slippage: an old tale with a new twist. Cell Cycle, 18(1), 7-15.
DOI Scopus117 Europe PMC108 |
| 2019 |
Kalimutho, M., Nones, K., Srihari, S., Duijf, P. H. G., Waddell, N., & Khanna, K. K. (2019). Patterns of Genomic Instability in Breast Cancer. Trends in Pharmacological Sciences, 40(3), 198-211.
DOI Scopus70 Europe PMC64 |
| 2019 |
Vahidian, F., Duijf, P. H. G., Safarzadeh, E., Derakhshani, A., Baghbanzadeh, A., & Baradaran, B. (2019). Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?. Immunology Letters, 208, 19-29.
DOI Scopus72 Europe PMC59 |
| 2019 |
Duijf, P. H. G., Nanayakkara, D., Nones, K., Srihari, S., Kalimutho, M., & Khanna, K. K. (2019). Mechanisms of Genomic Instability in Breast Cancer. Trends in Molecular Medicine, 25(7), 595-611.
DOI Scopus143 Europe PMC119 |
| 2019 |
Shirjang, S., Mansoori, B., Asghari, S., Duijf, P. H. G., Mohammadi, A., Gjerstorff, M., & Baradaran, B. (2019). MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis. Free Radical Biology and Medicine, 139, 1-15.
DOI Scopus152 Europe PMC112 |
| 2019 |
Ghasabi, M., Mansoori, B., Mohammadi, A., Duijf, P. H. G., Shomali, N., Shirafkan, N., . . . Baradaran, B. (2019). MicroRNAs in cancer drug resistance: Basic evidence and clinical applications. Journal of Cellular Physiology, 234(3), 2152-2168.
DOI Scopus68 Europe PMC47 |
| 2019 |
Asadzadeh, Z., Mansoori, B., Mohammadi, A., Aghajani, M., Haji-Asgarzadeh, K., Safarzadeh, E., . . . Baradaran, B. (2019). microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities. Journal of Cellular Physiology, 234(7), 10002-10017.
DOI Scopus92 Europe PMC67 |
| 2018 |
Hosseinahli, N., Aghapour, M., Duijf, P. H. G., & Baradaran, B. (2018). Treating cancer with microRNA replacement therapy: A literature review. Journal of Cellular Physiology, 233(8), 5574-5588.
DOI Scopus279 Europe PMC213 |
| 2018 |
Lin, C. Y., Shukla, A., Grady, J. P., Fink, J. L., Dray, E., & Duijf, P. H. G. (2018). Translocation breakpoints preferentially occur in euchromatin and acrocentric chromosomes. Cancers, 10(1), 1-19.
DOI Scopus18 |
| 2018 |
Lin, C. Y., Beattie, A., Baradaran, B., Dray, E., & Duijf, P. H. G. (2018). Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress. Scientific Reports, 8(1, article no. 13904), 1-12.
DOI Scopus30 Europe PMC25 |
| 2018 |
Joo, J. E., Dowty, J. G., Milne, R. L., Wong, E. M., Duijf, P., & Antill, Y. (2018). Heritable DNA methylation marks associated with susceptibility to breast cancer. Nature Communications, 9(1, article number 867), 1-12.
DOI Scopus84 Europe PMC82 |
| 2018 |
Shajari, N., Davudian, S., Kazemi, T., Mansoori, B., Salehi, S., Shahgoli, V. K., . . . Baradaran, B. (2018). Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression. Artificial Cells, Nanomedicine and Biotechnology, 46(7), 1495-1504.
DOI Scopus50 Europe PMC47 |
| 2018 |
Kalimutho, M., Sinha, D., Jeffery, J., Nones, K., Srihari, S., Fernando, W. C., . . . Khanna, K. K. (2018). CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer. EMBO Molecular Medicine, 10(9, article no. e8566), 1-22.
DOI Scopus71 Europe PMC68 |
| 2017 |
Thangavelu, P. U., Lin, C. Y., Vaidyanathan, S., Nguyen, T. H. M., Dray, E., & Duijf, P. H. G. (2017). Overexpression of the E2F target gene CENPI promotes chromosome instability and predicts poor prognosis in estrogen receptor-positive breast cancer. OncoTarget, 8(37), 62167-62182.
DOI Scopus43 Europe PMC34 |
| 2016 |
Vaidyanathan, S., Cato, K., Tang, L., Pavey, S., Haass, N. K., Gabrielli, B. G., & Duijf, P. H. G. (2016). In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis. Oncogene, 35(41), 5446-5455.
DOI Scopus49 Europe PMC49 |
| 2016 |
Vaidyanathan, S., Thangavelu, P. U., & Duijf, P. H. G. (2016). Overexpression of Ran GTPase components regulating nuclear export, but not mitotic spindle assembly, marks chromosome instability and poor prognosis in breast cancer. Targeted Oncology, 11(5), 677-686.
DOI Scopus40 Europe PMC34 |
| 2016 |
Thangavelu, P. U., Krenács, T., Dray, E., & Duijf, P. H. G. (2016). In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion. Clinical Epigenetics, 8(1, article no. 120), 1-13.
DOI Scopus68 Europe PMC62 |
| 2013 |
Duijf, P. H. G., Schultz, N., & Benezra, R. (2013). Cancer cells preferentially lose small chromosomes. International Journal of Cancer, 132(10), 2316-2326.
DOI Scopus144 Europe PMC146 |
| 2013 |
Duijf, P. H. G., & Benezra, R. (2013). The cancer biology of whole-chromosome instability. Oncogene, 32(40), 4727-4736.
DOI Scopus96 Europe PMC99 |
| 2011 |
Schvartzman, J. M., Duijf, P. H. G., Sotillo, R., Coker, C., & Benezra, R. (2011). Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell, 19(6), 701-714.
DOI Scopus154 Europe PMC156 |
| 2008 |
Rinne, T., Clements, S. E., Lamme, E., Duijf, P. H. G., Bolat, E., Meijer, R., . . . Van Bokhoven, H. (2008). A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromes. Human Molecular Genetics, 17(13), 1968-1977.
DOI Scopus59 Europe PMC50 |
| 2006 |
Rinne, T., Spadoni, E., Kjaer, K. W., Danesino, C., Larizza, D., Kock, M., . . . van Bokhoven, H. (2006). Delineation of the ADULT syndrome phenotype due to arginine 298 mutations of the p63 gene. European Journal of Human Genetics, 14(8), 904-910.
DOI Scopus45 Europe PMC34 |
| 2005 |
Duijf, P. H. G., & van Bokhoven, H. (2005). Ectodermal dysplasia: Skinny models on the catwalk. Drug Discovery Today Disease Models, 2(2), 111-118.
DOI |
| 2004 |
Bongers, E. M. H. F., Duijf, P. H. G., Van Beersum, S. E. M., Schoots, J., Van Kampen, A., Burckhardt, A., . . . Van Bokhoven, H. (2004). Mutations in the human TBX4 gene cause small patella syndrome. American Journal of Human Genetics, 74(6), 1239-1248.
DOI Scopus151 Europe PMC140 |
| 2003 |
Duijf, P. H. G., van Bokhoven, H., & Brunner, H. G. (2003). Pathogenesis of split-hand/split-foot malformation. Human Molecular Genetics, 12(REV. ISS. 1), R51-R60.
DOI Scopus180 Europe PMC134 |
| 2002 |
Ghioni, P., Bolognese, F., Duijf, P. H. G., Van Bokhoven, H., Mantovani, R., & Guerrini, L. (2002). Complex transcriptional effects of p63 isoforms: Identification of novel activation and repression domains. Molecular and Cellular Biology, 22(24), 8659-8668.
DOI Scopus203 Europe PMC172 |
| 2002 |
Duijf, P. H. G., Vanmolkot, K. R. J., Propping, P., Friedl, W., Krieger, E., McKeon, F., . . . Van Bokhoven, H. (2002). Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63. Human Molecular Genetics, 11(7), 799-804.
DOI Scopus113 Europe PMC90 |
| 2002 |
Serber, Z., Lai, H. C., Yang, A., Ou, H. D., Sigal, M. S., Kelly, A. E., . . . Dötsch, V. (2002). A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Molecular and Cellular Biology, 22(24), 8601-8611.
DOI Scopus178 Europe PMC155 |
| 2001 |
McGrath, J. A., Duijf, P. H. G., Doetsch, V., Irvine, A. D., De Waal, R., Vanmolkot, K. R. J., . . . Van Bokhoven, H. (2001). Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Human Molecular Genetics, 10(3), 221-229.
DOI Scopus348 Europe PMC278 |
| 2001 |
Van Bokhoven, H., Hamel, B. C. J., Bamshad, M., Sangiorgi, E., Gurrieri, F., Duijf, P. H. G., . . . Brunner, H. G. (2001). p63 gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. American Journal of Human Genetics, 69(3), 481-492.
DOI Scopus331 Europe PMC260 |
| 1999 |
Celli, J., Duijf, P., Hamel, B. C. J., Bamshad, M., Kramer, B., Smits, A. P. T., . . . Van Bokhoven, H. (1999). Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell, 99(2), 143-153.
DOI Scopus616 Europe PMC510 |
